Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Insight Molecular Diagnostics (IMDX) Equity Income: 2019-2021

Historic Equity Income for Insight Molecular Diagnostics (IMDX) over the last 3 years, with Dec 2021 value amounting to -$270,000.

  • Insight Molecular Diagnostics' Equity Income rose 17.93% to -$270,000 in Q1 2021 from the same period last year, while for Mar 2021 it was -$1.5 million, marking a year-over-year change of. This contributed to the annual value of -$270,000 for FY2021, which is 82.55% up from last year.
  • Per Insight Molecular Diagnostics' latest filing, its Equity Income stood at -$270,000 for FY2021, which was up 82.55% from -$1.5 million recorded in FY2020.
  • In the past 5 years, Insight Molecular Diagnostics' Equity Income ranged from a high of -$270,000 in FY2021 and a low of -$1.5 million during FY2020.
  • In the last 3 years, Insight Molecular Diagnostics' Equity Income had a median value of -$281,000 in 2019 and averaged -$699,333.
  • As far as peak fluctuations go, Insight Molecular Diagnostics' Equity Income plummeted by 450.53% in 2020, and later soared by 82.55% in 2021.
  • Yearly analysis of 3 years shows Insight Molecular Diagnostics' Equity Income stood at -$281,000 in 2019, then slumped by 450.53% to -$1.5 million in 2020, then spiked by 82.55% to -$270,000 in 2021.